Page last updated: 2024-11-13

alpha-conotoxin pnia

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-conotoxin PnIA: blocks neuronal acetylcholine receptors of Aplysia; isolated from the snail Conus pennaceus; amino acid sequence in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73755066
CHEMBL ID4443205
MeSH IDM0235488

Synonyms (10)

Synonym
alpha-conotoxin pnia
gtpl3982
?-conotoxin pnia
705300-84-1
AKOS024457442
s-705300-84-1
Q27074398
CHEMBL4443205 ,
bdbm50516319
a-conotoxin pnia
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuronal acetylcholine receptor subunit alpha-3Rattus norvegicus (Norway rat)IC50 (µMol)0.00770.00300.77706.0000AID1567307
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)IC50 (µMol)0.00770.00030.32092.3000AID1567307
Acetylcholine-binding proteinLymnaea stagnalis (great pond snail)Ki9.12010.00011.881128.0000AID1881439
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1567307Antagonist activity at rat alpha3beta2 nACHR expressed in Xenopus laevis oocytes by two electrode voltage-clamp assay2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors.
AID1881436Antagonist activity at human alpha3beta4 nAChR in SH-SY5Y cells assessed as inhibition of calcium flux at 10 uM by FLIPR assay2021RSC medicinal chemistry, Sep-23, Volume: 12, Issue:9
Posttranslational modifications of α-conotoxins: sulfotyrosine and C-terminal amidation stabilise structures and increase acetylcholine receptor binding.
AID1567311Selectivity ratio of IC50 for rat alpha6/alpha3beta2beta3 nAChR expressed in Xenopus laevis oocytes to IC50 for rat alpha3beta2 nACHR expressed in Xenopus laevis oocytes2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors.
AID1881439Displacement of [3H]-epibatidine from Lymnaea stagnalis Acetylcholine-binding protein measured after 1 hr by liquid scintillation counter2021RSC medicinal chemistry, Sep-23, Volume: 12, Issue:9
Posttranslational modifications of α-conotoxins: sulfotyrosine and C-terminal amidation stabilise structures and increase acetylcholine receptor binding.
AID1881435Antagonist activity at human alpha7 nAChR in SH-SY5Y cells assessed as inhibition of calcium flux at 10 uM by FLIPR assay2021RSC medicinal chemistry, Sep-23, Volume: 12, Issue:9
Posttranslational modifications of α-conotoxins: sulfotyrosine and C-terminal amidation stabilise structures and increase acetylcholine receptor binding.
AID1881438Displacement of [3H]-epibatidine from Aplysia californica Acetylcholine-binding protein measured after 1 hr by liquid scintillation counter2021RSC medicinal chemistry, Sep-23, Volume: 12, Issue:9
Posttranslational modifications of α-conotoxins: sulfotyrosine and C-terminal amidation stabilise structures and increase acetylcholine receptor binding.
AID1567308Antagonist activity at rat alpha6alpha3beta2beta3 nAChR expressed in Xenopus laevis oocytes by two electrode voltage-clamp assay2019Journal of medicinal chemistry, 07-11, Volume: 62, Issue:13
PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (40.00)18.2507
2000's5 (25.00)29.6817
2010's5 (25.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.41 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]